From: The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China
Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
White blood cell (×109/L) | 0.97 (0.84,1.12) | 0.655 | ||
NLR | 1.44 (1.23, 1.68) | < 0.001 | 0.99 (0.97, 1.01) | 0.048 |
T lymphocyte | 0.996 (0.994, 0.997) | < 0.001 | 0.99 (0.997, 0.999) | 0.002 |
CD4/CD8 | 1.02 (0.68, 1.52) | 0.939 | ||
TBIL | 1.02 (0.98, 1.06) | 0.325 | ||
ALP | 0.99 (0.98, 1.00) | 0.067 | ||
Troponin T | 0.92 (0.60, 1.51) | 0.738 | ||
CRP | 1.04 (1.02, 1.05) | < 0.001 | 1.67 (1.12, 2.47) | 0.012 |
PCT | 0.90 (0.32, 2.51) | 0.833 | ||
IL-6 | 1.05 (1.03, 1.07) | < 0.001 | 1.03 (1.00, 1.05) | 0.008 |
ESR | 1.02 (1.00–1.03) | 0.002 | 0.99 (0.97, 1.01) | 0.529 |
D-Dimer | 1.78 (1.02, 3.09) | 0.052 | ||
Ferritin | 1.00 (1.000–1.001) | 0.189 |